Back to all studies
Recruitment unclearNCT04336605

Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents

This study has public registry information. It focuses on PTSD and currently lists study information in Norway.

PTSD, Addiction, ...OtherFrom 13 Years to 32 Years

Important: this study may not currently be recruiting. HopeStage shows this page to help people understand the study information, but you should verify the current status with the official registry and research team.

Need help deciding?

Ask HopeStage to help me review this study

This study may no longer be open, but we can help you understand it and find similar studies.

Loading the security check...
Study ID: NCT04336605. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether Age & Development may be useful for adolescents experiencing ptsd.

What would participation involve?

Participants may complete study activities around Age & Development, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in Norway.

Who is it mainly for?

This study appears to be mainly for adolescents with ptsd. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruitment unclear
Estimated enrollment
25,000
Sponsor
Norwegian Center for Violence and Traumatic Stress Studies
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
Norway
Age range
From 13 Years to 32 Years
Official registry ID
NCT04336605
Official title
Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents
Official source
Official registry link

Ask HopeStage to help me review this study

This study may no longer be open, but we can help you understand it and find similar studies.

Loading the security check...
Study ID: NCT04336605. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: Prescription of analgesic, sedative, and anxiolytic medication for children and adolescents is increasing in Western countries. In recent decades, rates have also increased in Norway, despite a relatively restrictive prescription practice. Analgesics, sedatives, and anxiolytics. The study team can confirm the exact objective and what it means for you.

Why is the study type not clearly categorized?

The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.

Do I need to want to stop or reduce tobacco use to participate?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What risks or points should I check?

The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Norwegian Center for Violence and Traumatic Stress Studies, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The recruitment status is not clearly listed. Check the official registry or contact the study team. The registry lists an estimated enrollment of 25,000 participants.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me